⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL780236 | 0.82 | — | — | |
| SCHEMBL8990608 | 0.76 | PARP1 (0.42) | — | |
| SCHEMBL284637 | 0.76 | — | — | |
| SCHEMBL29998594 | 0.75 | KMT2A (0.33) | — | |
| Iodide SCHEMBL5464242 | 0.74 | NAMPT (0.44) | — | |
| Lithium SCHEMBL31348018 | 0.74 | NAMPT (0.44) | — | |
| SCHEMBL151256 | 0.71 | ALDH1A1 (0.42) | — | |
| SCHEMBL12410703 | 0.71 | TTK (0.33) | — | |
| SCHEMBL13496087 | 0.71 | NNMT (0.33) | — | |
| SCHEMBL3810263 | 0.71 | ALDH1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082652-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | UNIVERSITÄT ZU KÖLN (DE) | 2025-03-13 | — | — | US | claimed |
| EP-4460301-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | Universität zu Köln (DE) | 2024-11-13 | — | — | EP | claimed |
| EP-3720493-B1 | COMBINATIONS OF RIPK1- AND IKK-INHIBITORS FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES | UNIV KOELN (DE) | 2024-07-24 | — | — | EP | claimed |
| WO-2023131576-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | UNIVERSITÄT ZU KÖLN (DE) | 2023-07-13 | — | — | WO | claimed |
| EP-4209213-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | Universität zu Köln (DE) | 2023-07-12 | — | — | EP | claimed |
| WO-2010147663-A1 | METHODS AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF ANEUPLOID CELLS | MASSECHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-12-23 | — | — | WO | claimed |
| CN-101842095-A | Formulations, methods and targets for tumor therapy | MING YU | 2010-09-22 | — | — | CN | claimed |
| EP-2178531-A2 | METHODS, COMPOSITION, TARGETS FOR COMBINATIONAL CANCER TREATMENTS | Yu, Ming (US) | 2010-04-28 | — | — | EP | claimed |
| WO-2009006555-A2 | METHODS, COMPOSITION, TARGETS FOR COMBINATIONAL CANCER TREATMENTS | YU, MING (US) | 2009-01-08 | — | — | WO | claimed |
| EP-1888060-A2 | NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY | A. T. Still University of Health Sciences (US) | 2008-02-20 | — | — | EP | claimed |
| US-20060280812-A1 | Compositions and methods for the treatment of muscular dystrophy | A.T. STILL UNIVERSITY OF HEATH SCIENCES | 2006-12-14 | — | — | US | claimed |
| WO-2006127930-A2 | NK-B INHIBITORS FOR THE TREATMENT OF MUSCULAR DYSTROPHY | A. T. STILL UNIVERSITY OF HEALTH SCIENCES (US) | 2006-11-30 | — | — | WO | claimed |
| US-20030166201-A1 | Selection systems for genetically modified cells | CITY OF HOPE | 2003-09-04 | — | — | US | claimed |
| US-20250144105-A1 | CDK9 INHIBITORS | ORIGENIS GMBH (DE) | 2025-05-08 | — | — | US | disclosed |
| US-20250082652-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | UNIVERSITÄT ZU KÖLN (DE) | 2025-03-13 | — | — | US | disclosed |
| EP-4460301-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | Universität zu Köln (DE) | 2024-11-13 | — | — | EP | disclosed |
| EP-0432677-A1 | N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-06-19 | — | — | EP | disclosed |
| US-5013738-A | L-glutamic acid derivatives | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-05-07 | — | — | US | disclosed |
| EP-0405370-A1 | Riboflavinoverproducing strains of bacteria | F. HOFFMANN-LA ROCHE AG (CH) | 1991-01-02 | — | — | EP | disclosed |
| US-4920125-A | L-glutamic acid derivatives | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1990-04-24 | — | — | US | disclosed |